Found: 5
Select item for more details and to access through your institution.
Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29444-9
- By:
- Publication type:
- Article
Patient-derived tumor xenograft and organoid models established from resected pancreatic, duodenal and biliary cancers.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-90049-1
- By:
- Publication type:
- Article
First‐in‐human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC‐2394, in healthy volunteers.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 9, p. 1653, doi. 10.1111/cts.13576
- By:
- Publication type:
- Article
Somatic Alteration Burden Involving Non-Cancer Genes Predicts Prognosis in Early-Stage Non-Small Cell Lung Cancer.
- Published in:
- Cancers, 2019, v. 11, n. 7, p. 1009, doi. 10.3390/cancers11071009
- By:
- Publication type:
- Article
Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
- Published in:
- International Journal of Cancer, 2017, v. 140, n. 3, p. 662, doi. 10.1002/ijc.30472
- By:
- Publication type:
- Article